AI
| Followers | 600 |
| Posts | 24109 |
| Boards Moderated | 3 |
| Alias Born | 12/06/2009 |
Tuesday, November 27, 2018 9:22:49 PM
we could be wrong man..
but what if...
we're right?
What if. Sanofi Exclusive Licenses the Virosomes for Flu, What if Mymetics Virosomes get included in the next big "Flu-zone" product to sell 1.9 Billion per year?
What if. Anergis Exclusive Licenses the Virosomes for Allergies for 2-4 Billion per year?
What if Uncle Bill and the EU funds MACIVIA all the way to the finish line and Catalent and Upperton taking orders from multiple vaccine companies for the next 20 years ?
What if the LMIV drop 100 million on Mymetics to develop their Multi-stage transmission blocker for Malaria?
What if EtheRNA licenses the virosomes for their cancer DNA vaccines with Johnson and Johnson for 100 Million+
The last RSV deal got an 80 Million dollar contract, oh but we have a new generation ready to sell as well now don't we?
All of these deals an more, all generating upfront, royalties, milestone payments long term revenues.
Sayonara dude. Cya in Dollar land. $MYMX
but what if...
we're right?
What if. Sanofi Exclusive Licenses the Virosomes for Flu, What if Mymetics Virosomes get included in the next big "Flu-zone" product to sell 1.9 Billion per year?
What if. Anergis Exclusive Licenses the Virosomes for Allergies for 2-4 Billion per year?
What if Uncle Bill and the EU funds MACIVIA all the way to the finish line and Catalent and Upperton taking orders from multiple vaccine companies for the next 20 years ?
What if the LMIV drop 100 million on Mymetics to develop their Multi-stage transmission blocker for Malaria?
What if EtheRNA licenses the virosomes for their cancer DNA vaccines with Johnson and Johnson for 100 Million+
The last RSV deal got an 80 Million dollar contract, oh but we have a new generation ready to sell as well now don't we?
All of these deals an more, all generating upfront, royalties, milestone payments long term revenues.
Sayonara dude. Cya in Dollar land. $MYMX
